WHO ICTRP trial
Long-term safety study of personalized cholic acid treatment in patients with…
NL-OMON25657 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON25657 |
|---|---|
| Public title | Long-term safety study of personalized cholic acid treatment in patients with bile acid synthesis defects |
| Scientific title | Long-term safety study of personalized cholic acid treatment in patients with bile acid synthesis defects |
| Primary sponsor | Amsterdam UMC |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Conditions | Bile acid synthesis defects (BASD), 3ß-hydroxy-?5-C27-steroid oxidoreductase, ?4-3-oxosteroid-5ß-reductase, cholesterol 7a-hydroxylase (CYP7A1), and a-methylacyl-CoA racemase (AMACR), Zellweger spectrum disorder |
| Interventions | Cholic Acid |
| Registration date | May 18, 2020 |
| Target size | 40 |
| Secondary IDs | NL8630;METC AMC : 2019_192 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: